PSF Translational and Innovation Research Grant
The PSF translational research grant provides funding to support novel translational innovative research (e.g. devices, diagnostics, technology, etc.) that accelerates discovery through FDA approval into clinical testing. The research must lead to improvements in commercial development, and the objectives of the project should include an outcome that will benefit patients and address unmet clinical needs.
Projects should be milestone-driven and not discovery, hypothesis-based research. The grant is intended to support a viable commercial product, with plan for commercialization within three years. Projects with a clear path to market and go/no-go milestones will be favorably reviewed.
Amount & Duration
Up to $50,000 for 1-year projects; can apply for additional funding in year 2
The 2022 PSF research grant cycle is NOW CLOSED.
The application deadline was December 1, 2021.